Premium
Pediatric Continuous Renal Replacement Therapy (PCRRT) expert committee recommendation on prescribing prolonged intermittent renal replacement therapy (PIRRT) in critically ill children
Author(s) -
Sethi Sidharth Kumar,
Mittal Aliza,
Nair Nikhil,
Bagga Arvind,
Iyenger Arpana,
Ali Uma,
Sinha Rajiv,
Agarwal Indira,
Sousa Tavares Marcelo,
Abeyagunawardena Asiri,
Hanif Mohammed,
Shreshtha Devender,
Moorani Khemchand,
Asim Sadaf,
Kher Vijay,
Alhasan Khalid,
Mourani Chebl,
Al Riyami Mohammed,
Bunchman Timothy E.,
McCulloch Mig,
Raina Rupesh
Publication year - 2020
Publication title -
hemodialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.658
H-Index - 47
eISSN - 1542-4758
pISSN - 1492-7535
DOI - 10.1111/hdi.12821
Subject(s) - medicine , renal replacement therapy , workgroup , intensive care medicine , medline , critically ill , medical prescription , population , nursing , computer network , environmental health , computer science , political science , law
Recently, prolonged intermittent renal replacement therapies (PIRRT) have emerged as cost‐effective alternatives to conventional CRRT and their use in the pediatric population has started to become more prominent. However, there is a lack of consensus guidelines on the use of PIRRT in pediatric patients in an intensive care setting. Methods A literature search was performed on PubMed/Medline, Embase, and Google Scholar in conjunction with medical librarians from both India and the Cleveland Clinic hospital system to find relevant articles. The Pediatric Continuous Renal Replacement Therapy workgroup analyzed all articles for relevancy, proposed recommendations, and graded each recommendation for their strength of evidence. Results Of the 60 studies eligible for review, the workgroup considered data from 37 studies to formulate guidelines for the use of PIRRT in children. The guidelines focused on the definition, indications, machines, and prescription of PIRRT. Conclusion Although the literature on the use of PIRRT in children is limited, the current studies give credence to their benefits and these expert recommendations are a valuable first step in the continued study of PIRRT in the pediatric population.